Daliom Biopharmaceuticals develops therapeutic proteins, such as monoclonal antibodies and recombinant proteins, to treat a range of diseases. This includes immunotherapy for cancer, as well as treatments for autoimmune disorders, rare diseases, and infectious diseases.
Daliom Biopharmaceuticals Ltd. 123 Main Street, Zurich, Switzerland, ZIP Code: 8001. Registration №: CH-123456.7890.12-4.
We refuse unauthorized email collection
We refuse the unauthorized collection of the email addresses on this website using email collection programs or other technical devices. Please note that any violation will be subject to criminal penalties in accordance with the Act on Information and Communications Network.
Posted on March 28, 2023
This site uses cookies.
By continuing to browse the site,
you agree to the use of cookies.
